About

MITRO, founded in 2012, is the first molecular imaging CRO company in China. By applying Radiolabeling and Molecular Imaging techniques, MITRO provides outstanding services including preclinical and clinical drug screening, bio-distribution, pharmacokinetics and pharmacodynamics. MITRO can provide one-stop service for radiopharmaceuticals including in vitro discovery, radiochemistry, pre-clinical study, clinical study and registration. About MITRO BIOTECH CO.,LTD. Established in 2012, MITRO Biotech Co., Ltd. focuses on providing professional and efficient CRO and CDMO services of radioisotope labelled molecular imaging to the global pharmaceutical and biopharmaceutical industries. Headquartered in Jiangning District, Nanjing City, it currently has offices in China, the United States, and the United Kingdom with over 200 employees worldwide. With complete qualifications and facilities, MITRO currently has a radioactive laboratory certified by AAALAC, which can meet the animal welfare standards at home and abroad. It has 26 kinds of nuclide qualifications that can meet various experimental requirements. It is a CRO company with clinical and animal PET/CT, which can realize continuous dynamic and static scanning of large and small animals. Mitro has dived into the field of nuclear medicine for many years, with a solid business foundation, brand power, and years of rich project experience. About MITRO Biotech Co.,Ltd. Established in 2012, MITRO Biotech Co., Ltd. focuses on providing professional and efficient CRO and CDMO services of radioisotope labelled molecular imaging to the global pharmaceutical and biopharmaceutical industries. Headquartered in Jiangning District, Nanjing City, it currently has offices in China, the United States, and the United Kingdom with over 200 employees worldwide. With complete qualifications and facilities, MITRO currently has a radioactive laboratory certified by AAALAC, which can meet the animal welfare standards at home and abroad. It has 26 kinds of nuclide qualifications that can meet various experimental requirements. It is a CRO company with clinical and animal PET/CT, which can realize continuous dynamic and static scanning of large and small animals. Mitro has dived into the field of nuclear medicine for many years, with a solid business foundation, brand power, and years of rich project experience. MITRO, established in 2012, currently has offices in USA, UK and China with over 180 staff members. MITRO has over 86,000 sq ft. of radiolabeling and AAALAC accredited animal facility including rodents and NHPs. MITRO focuses on providing professional and efficient CRO and CDMO services of radiolabeling and molecular imaging to the global pharmaceutical and biopharmaceutical industries. MITRO in USA is based in New Haven, CT with over 24,000 sq ft. of research space. MITRO USA is organized into Clinical, Chemistry, and Imaging Sciences Divisions with administrative and project support including regulatory affairs, QA, data, IT, and business operations. Our research staff has leadership roles in numerous clinical imaging trials focused on neuroscience and radiopharmaceuticals aimed at the causes and developing more effective treatments for neurodegenerative disorders.